Vaginal Microbiomes Associated With Aerobic Vaginitis and Bacterial Vaginosis.

Evelyn Kaambo, Charlene Africa, Ramadhani Chambuso, Jo-Ann Shelley Passmore
Author Information
  1. Evelyn Kaambo: Genital Mucosal HIV and STI Research Group, Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Medical Virology Laboratory, Cape Town, South Africa.
  2. Charlene Africa: MENIS, Medical Biosciences, University of the Western Cape, Bellville, South Africa.
  3. Ramadhani Chambuso: Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  4. Jo-Ann Shelley Passmore: Genital Mucosal HIV and STI Research Group, Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Medical Virology Laboratory, Cape Town, South Africa.

Abstract

A healthy vaginal microbiota is considered to be significant for maintaining vaginal health and preventing infections. However, certain vaginal bacterial commensal species serve an important first line of defense of the body. Any disruption of this microbial barrier might result in a number of urogenital conditions including aerobic vaginitis (AV) and bacterial vaginosis (BV). The health of the vagina is closely associated with inhabitant microbiota. Furthermore, these microbes maintain a low vaginal pH, prevent the acquisition of pathogens, stimulate or moderate the local innate immune system, and further protect against complications during pregnancies. Therefore, this review will focus on vaginal microbial "health" in the lower reproductive tract of women and on the physiological characteristics that determine the well-being of reproductive health. In addition, we explore the distinct versus shared characteristics of BV and AV, which are commonly associated with increased risk for preterm delivery.

Keywords

References

  1. Am J Obstet Gynecol. 1981 Jul 1;140(5):515-20 [PMID: 7018248]
  2. Am J Obstet Gynecol. 2011 Feb;204(2):120.e1-5 [PMID: 20832044]
  3. Anaerobe. 2011 Aug;17(4):191-5 [PMID: 21376827]
  4. Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7 [PMID: 20534435]
  5. J Microbiol Methods. 2015 Jan;108:31-5 [PMID: 25447890]
  6. BJOG. 2011 Sep;118(10):1163-70 [PMID: 21668769]
  7. J Reprod Immunol. 2011 Mar;88(2):185-94 [PMID: 21353708]
  8. BJOG. 2002 Jan;109(1):34-43 [PMID: 11845812]
  9. PLoS One. 2016 Jan 26;11(1):e0148052 [PMID: 26811897]
  10. Ginekol Pol. 2013 May;84(5):352-8 [PMID: 23819400]
  11. Vaccine. 2013 Aug 28;31 Suppl 4:D7-12 [PMID: 23973349]
  12. BMC Pregnancy Childbirth. 2014 Mar 19;14:107 [PMID: 24641730]
  13. Vaccine. 2014 Apr 7;32(17):1954-63 [PMID: 24530145]
  14. Reprod Sci. 2012 Mar;19(3):235-42 [PMID: 22383775]
  15. Clin Ther. 2008 Mar;30(3):453-68 [PMID: 18405785]
  16. PLoS One. 2014 Jun 30;9(6):e98778 [PMID: 24979575]
  17. BMC Infect Dis. 2009 Sep 11;9:153 [PMID: 19747377]
  18. Annu Rev Microbiol. 2012;66:371-89 [PMID: 22746335]
  19. BJOG. 2009 Sep;116(10):1315-24 [PMID: 19538417]
  20. Med Hypotheses. 2009 Dec;73(6):963-75 [PMID: 19942083]
  21. Semin Fetal Neonatal Med. 2012 Feb;17(1):51-7 [PMID: 21920833]
  22. mBio. 2010 Aug 24;1(3): [PMID: 20824105]
  23. Pediatr Clin North Am. 1999 Aug;46(4):733-45, xi [PMID: 10494254]
  24. Curr Infect Dis Rep. 2015 May;17(5):477 [PMID: 25896749]
  25. J Appl Microbiol. 2011 May;110(5):1105-28 [PMID: 21332897]
  26. Ann Ig. 2013 Sep-Oct;25(5):443-56 [PMID: 24048183]
  27. Afr J Reprod Health. 2017 Jun;21(2):108-118 [PMID: 29624945]
  28. Adolesc Med Clin. 2004 Jun;15(2):235-51 [PMID: 15449843]
  29. Best Pract Res Clin Obstet Gynaecol. 2007 Jun;21(3):355-73 [PMID: 17434799]
  30. J Gen Intern Med. 1998 May;13(5):335-46 [PMID: 9613891]
  31. Crit Rev Microbiol. 2011 Aug;37(3):250-61 [PMID: 21599498]
  32. BMC Womens Health. 2015 May 13;15:42 [PMID: 25968607]
  33. Arch Gynecol Obstet. 2015 Feb;291(2):251-7 [PMID: 25367602]
  34. Obstet Gynecol. 2005 Jan;105(1):18-23 [PMID: 15625136]
  35. Eur J Clin Microbiol Infect Dis. 2013 Aug;32(8):977-84 [PMID: 23443475]
  36. Ann N Y Acad Sci. 2011 Aug;1230:48-58 [PMID: 21824165]
  37. J Infect Dis. 2014 Jul 15;210(2):265-73 [PMID: 24474814]
  38. Am J Obstet Gynecol. 2007 Jun;196(6):524.e1-5 [PMID: 17547879]
  39. Appl Environ Microbiol. 2013 Mar;79(6):1835-42 [PMID: 23315732]
  40. Arch Gynecol Obstet. 2012 Aug;286(2):325-32 [PMID: 22437191]
  41. Gynecol Obstet Invest. 2010;70(4):244-9 [PMID: 21051843]
  42. Vaccine. 2013 Aug 28;31 Suppl 4:D66-71 [PMID: 23200934]

Word Cloud

Created with Highcharts 10.0.0vaginalhealthbacterialmicrobiotamicrobialaerobicvaginitisAVvaginosisBVassociatedreproductivecharacteristicspretermhealthyconsideredsignificantmaintainingpreventinginfectionsHowevercertaincommensalspeciesserveimportantfirstlinedefensebodydisruptionbarriermightresultnumberurogenitalconditionsincludingvaginacloselyinhabitantFurthermoremicrobesmaintainlowpHpreventacquisitionpathogensstimulatemoderatelocalinnateimmunesystemprotectcomplicationspregnanciesThereforereviewwillfocus"health"lowertractwomenphysiologicaldeterminewell-beingadditionexploredistinctversussharedcommonlyincreasedriskdeliveryVaginalMicrobiomesAssociatedAerobicVaginitisBacterialVaginosisgroupBStreptococcusbirthmicrobiomes

Similar Articles

Cited By